Abstract
A review of key placebo-controlled studies of benzodiazepines and selective serotonin reuptake inhibitors (SSR Is) over the past decade challenges the widespread view that placebo response rates resulting from clinical trials of pharmacotherapy for panic disorder are excessively high. Statistically and clinically significant drug-placebo differences have been demonstrated in large-scale trials. Further research is needed on the impact of pharmacological treatments on the medium- and long-term course of the disorder.
| Original language | English (US) |
|---|---|
| Journal | Bulletin of the Menninger Clinic |
| Volume | 60 |
| Issue number | 2 SUPPL. |
| State | Published - Mar 1996 |
Fingerprint
ASJC Scopus subject areas
- Psychiatry and Mental health
- Clinical Psychology
Cite this
Placebo response in the treatment of panic disorder. / Hirschfeld, Robert M A.
In: Bulletin of the Menninger Clinic, Vol. 60, No. 2 SUPPL., 03.1996.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Placebo response in the treatment of panic disorder
AU - Hirschfeld, Robert M A
PY - 1996/3
Y1 - 1996/3
N2 - A review of key placebo-controlled studies of benzodiazepines and selective serotonin reuptake inhibitors (SSR Is) over the past decade challenges the widespread view that placebo response rates resulting from clinical trials of pharmacotherapy for panic disorder are excessively high. Statistically and clinically significant drug-placebo differences have been demonstrated in large-scale trials. Further research is needed on the impact of pharmacological treatments on the medium- and long-term course of the disorder.
AB - A review of key placebo-controlled studies of benzodiazepines and selective serotonin reuptake inhibitors (SSR Is) over the past decade challenges the widespread view that placebo response rates resulting from clinical trials of pharmacotherapy for panic disorder are excessively high. Statistically and clinically significant drug-placebo differences have been demonstrated in large-scale trials. Further research is needed on the impact of pharmacological treatments on the medium- and long-term course of the disorder.
UR - http://www.scopus.com/inward/record.url?scp=0029979893&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029979893&partnerID=8YFLogxK
M3 - Article
VL - 60
JO - Bulletin of the Menninger Clinic
JF - Bulletin of the Menninger Clinic
SN - 0025-9284
IS - 2 SUPPL.
ER -